DelMar Pharmaceuticals Receives Nasdaq Listing Extension
Vancouver, BC and Menlo Park, CA Feb. 7, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new cancer therapies,… Read More



